Antituberculous drug-induced liver injury: current perspective
about
Hepatotoxicity from antituberculous therapy in the elderly: a systematic reviewLiver Transplantation in India: At the CrossroadsCytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohortAnti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control studyThe incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1In silico evaluation and exploration of antibiotic tuberculosis treatment regimensA prospective, observational study of adverse reactions to drug regimen for multi-drug resistant pulmonary tuberculosis in central India.Drug-induced hepatitis and the risk factors for liver injury in pulmonary tuberculosis patients.Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicity.Successful desensitization therapy involving fluoroquinolone for the treatment of a solitary tuberculoma: A case report and literature reviewHepatobiliary Quiz Answers - 18 (2016).Clinical Characteristics of Patients with Drug-induced Liver Injury.Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India.Ischaemic Markers in Acute Hepatic Injury.Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study.Liver transplantation for acute liver failure due to antitubercular drugs – a single-center experience.Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
P2860
Q27022370-CCE8C719-A40A-45A1-8A1C-2BBF359048DEQ28080234-60D3D84E-EDC7-40FA-AAE1-751B906B5C51Q28486869-8046A5A7-81BF-478E-BF9F-873C44B696A0Q28488142-14EBA1E3-9DF9-4B50-A63B-CBA415E620F0Q28539060-C99A2672-F616-43A9-B8DC-09DB19873C37Q28607283-FFF16E60-1227-4C81-BDD0-AA53885D2698Q34194183-06B2F65B-38D4-4764-BF0B-7883BEAE94F7Q35534713-C483708E-0D7C-4C49-9E5C-7E3DE7665D52Q36145491-B052375A-1774-4F53-818D-DD9AECB80CA2Q37001245-6DF55127-1D64-4386-BC16-4638E5974634Q37131606-82103DB8-CA30-428E-A346-7F8D8AD9D639Q37615556-31921C6A-B2A5-486F-80D4-FAC91C69CBFCQ40723805-5549C3F3-32AF-464B-8E06-BC5F38DC8C79Q41518482-84E87110-151A-48D6-B15A-017DBB33271FQ52625145-5BE89153-160E-4E19-93DC-54BD1E8EB240Q55268147-48ACCE36-4933-496F-A5E6-5DFDF738186FQ56969466-BE0A77FB-A4CD-4C66-B5AD-8BEDC8C3CEC5
P2860
Antituberculous drug-induced liver injury: current perspective
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antituberculous drug-induced liver injury: current perspective
@ast
Antituberculous drug-induced liver injury: current perspective
@en
Antituberculous drug-induced liver injury: current perspective
@nl
type
label
Antituberculous drug-induced liver injury: current perspective
@ast
Antituberculous drug-induced liver injury: current perspective
@en
Antituberculous drug-induced liver injury: current perspective
@nl
prefLabel
Antituberculous drug-induced liver injury: current perspective
@ast
Antituberculous drug-induced liver injury: current perspective
@en
Antituberculous drug-induced liver injury: current perspective
@nl
P3181
P1476
Antituberculous drug-induced liver injury: current perspective
@en
P2093
Harshad Devarbhavi
P304
P3181
P407
P577
2011-07-01T00:00:00Z